RLYB (STOCKS)
Rallybio Corporation Common Stock
$8.300000
-0.140000 (-1.66%)
Prev close: $8.440000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Stephen Uden
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $43.96M
- Employees
- 20
- P/E (TTM)
- -4.94
- P/B (TTM)
- 0.77
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
4
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.03 | $-1.20 | +0.1668 | +13.94% |
|
Sep 2025 (Q3)
|
$-1.12 | $-1.75 | +0.6289 | +35.96% |
|
Jun 2025 (Q2)
|
$-1.76 | $-2.00 | +0.2392 | +11.96% |
|
Mar 2025 (Q1)
|
$-1.68 | $-2.12 | +0.4416 | +20.81% |
Financial Statements
| Revenues | $858.00K |
| Benefits Costs and Expenses | $9.84M |
| Costs And Expenses | $9.84M |
| Nonoperating Income/Loss | $24.96M |
| Operating Expenses | $33.92M |
| Depreciation and Amortization | $92.00K |
| Research and Development | $19.60M |
| Other Operating Expenses | $14.23M |
| Operating Income/Loss | -$33.06M |
| Income/Loss Before Equity Method Investments | -$8.10M |
| Income/Loss From Continuing Operations After Tax | -$8.98M |
| Income/Loss From Continuing Operations Before Tax | -$8.98M |
| Income/Loss From Equity Method Investments | -$874.00K |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$8.98M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$8.98M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.98M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.59 |
| Diluted Earnings Per Share | -$1.59 |
| Basic Average Shares | 5,629,370 |
| Diluted Average Shares | 5,629,370 |
| Assets | $62.26M |
| Current Assets | $61.25M |
| Cash | $54.70M |
| Other Current Assets | $6.55M |
| Noncurrent Assets | $1.01M |
| Fixed Assets | $23.00K |
| Other Non-current Assets | $985.00K |
| Liabilities | $4.31M |
| Current Liabilities | $4.22M |
| Accounts Payable | $126.00K |
| Other Current Liabilities | $4.10M |
| Noncurrent Liabilities | $82.00K |
| Equity | $57.96M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $57.96M |
| Liabilities And Equity | $62.26M |
| Net Cash Flow From Operating Activities | -$29.81M |
| Net Cash Flow From Operating Activities, Continuing | -$29.81M |
| Net Cash Flow From Investing Activities | $47.27M |
| Net Cash Flow From Investing Activities, Continuing | $47.27M |
| Net Cash Flow From Financing Activities | $16.00K |
| Net Cash Flow From Financing Activities, Continuing | $16.00K |
| Net Cash Flow | $17.47M |
| Net Cash Flow, Continuing | $17.47M |
| Comprehensive Income/Loss | -$9.03M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$9.03M |
| Other Comprehensive Income/Loss | -$50.00K |